[1]
Abd-rabou, A., Ahmed, H. and Eskander, E. 2017. CLEMASTINE, THE H1 HISTAMINE RECEPTOR ANTAGONIST, ALTERS THE HUMAN SEX AND THYROID HORMONAL PROFILES. Asian Journal of Pharmaceutical and Clinical Research. 10, 8 (Aug. 2017), 327-330. DOI:https://doi.org/10.22159/ajpcr.2017.v10i8.19456.